EVOLUS, INC. Increase (Decrease) in Other Noncurrent Assets
EVOLUS, INC. (EOLS) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2018-11-05
- EVOLUS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- EVOLUS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2017-09-30 was $1.23M.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month |
|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 | ||
| 2017-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $1.38M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $157.00K 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |